The tweet was deleted by the author.
But we saved everything 🙂.
Stereotaxis, Inc. announced that over 500 peer-reviewed publications have validated the safety, efficacy, and efficiency of its robotic electrophysiology solutions.
The company encouraged interested parties to review the amassed clinical data, signaling continued confidence in the scientific foundation underpinning its robotic technology in electrophysiology procedures.
Stereotaxis previously launched a hiring campaign for roles focused on healthcare innovation. The company has also promoted its RoboticEP technology as a tool to address physician burnout and improve patient care. These initiatives reflect ongoing efforts to expand the adoption and impact of its robotics platform in clinical settings.